Learning advanced experience and facing up to its own gap-Zhenyuan Kungang visit learning
Release time:
2022-01-17
11# January 4 , Yunnan Jianfeng Cement Company organized middle-level managers and key personnel to visit Zhenyuan Kungang. All the personnel who have been there were deeply shocked by the company's achievements in on-site management and optimization of economic and technical indicators. In order to enable us to understand our own gap and to start to change our thinking in order to improve all aspects of the subsequent enterprise, 11# may 29 , my colleagues and I also went to Kungang for a visit and study.
After communicating with the company's general assistant in charge of production and the manager of the manufacturing department, I was very shocked. Last year9# December, their standard coal consumption per ton of clinker was 102-103 kg / tons, the comprehensive power consumption per ton of clinker was / tons when 52.0 kW, and the auxiliary power consumption per ton of clinker was / tons when 2.0 kW. In a short period of one year, without large-scale technological transformation, these three indexes have dropped to the current 97.0 kg / tons, 49-50.0 kW / tons and 1.4 kW / tons. the operation stability of the kiln system has also been greatly improved, with continuous operation days reaching 98 days. Compared with recent years, in addition to the kiln production, most of the indicators of our clinker firing system are still standing still or even regressing. I feel very ashamed. After a half-hour field visit to the production site of
4, up to the highest preheater, down to the limestone homogenization pile shed pit, and even the most difficult point in site management - clinker warehouse roof, they basically have no sanitary dead corners, equipment and ground are spotless, and each pouring hole and manhole door of the preheater is fully welded or sealed, the on-site management is quite different from the situation when I visited the company in 2019 . In communicating with the company's managers, I think there are two spirits that are worth learning. The first is perseverance, whether in the management of running and dripping, or the optimization of economic and technical indicators, are focused on the target, continuous optimization, after a continuous period of
3-4years to reach the current state. The second is to be more true, not to let go of any details of improvement, and to find and solve problems constantly with the attitude of "method is always more difficult than " . The chief of the production and manufacturing department of the company was very proud when he introduced some effective improvement experiences on the spot during the visit with us. Employees have also gained a sense of achievement while making efforts, which makes the whole working atmosphere exudes a positive atmosphere.
After returning to the company, I worked overtime to produce
PPTfor publicity in each team and group, introducing in detail the successful experience of Kungang, making the employees aware of our gap. In the future, some measures will be gradually introduced to strengthen the management of on-site leakage, on-site renovation and optimization of economic and technical indicators, and catch up with each other in a serious and serious manner to narrow the gap. (Song Xiaofei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page